NEFL and Alzheimer disease: In addition to other biomarkers such as amyloid beta (Aβ) and tau protein, elevated levels of NfL in both the CSF and blood have been shown to differentiate healthy controls from subjects with AD with reliable accuracy [3, 5–9].